{
    "root": "2a79d440-2b83-c291-e063-6294a90a55c9",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Isoflurane",
    "value": "20250325",
    "ingredients": [
        {
            "name": "ISOFLURANE",
            "code": "CYS9AKD70P"
        }
    ],
    "indications": "isoflurane usp may used induction maintenance general anesthesia . adequate data developed establish application obstetrical anesthesia .",
    "contraindications": "\u2022 isoflurane usp administered persons trained general anesthesia . isoflurane usp delivered using vaporizer specifically designed designated isoflurane . ( 2 ) \u2022 general anesthesia must individualized titrated based patient \u2019 age status . ( 2 )",
    "warningsAndPrecautions": "isoflurane usp , available following presentations : fill container ndc 100 ml amber-colored bottle 66794-017-10 250 ml amber-colored bottle 66794-017-25 replace cap securely .",
    "adverseReactions": "isoflurane usp contraindicated patients : \u2022 general anesthesia contraindicated . \u2022 known sensitivity isoflurane usp halogenated agents [ ( 5.3 ) ] . \u2022 known suspected genetic susceptibility malignant hyperthermia [ ( 5.1 ) , pharmacology ( 12.5 ) ] . \u2022 history confirmed hepatitis due halogenated inhalational anesthetic history unexplained moderate severe hepatic dysfunction ( e.g . , jaundice associated fever and/or eosinophilia ) anesthesia isoflurane halogenated inhalational anesthetics .",
    "indications_original": "Isoflurane USP may be used for induction and maintenance of general anesthesia. Adequate data have not been developed to establish its application in obstetrical anesthesia.",
    "contraindications_original": "\u2022 Isoflurane USP should be administered only by persons trained in the administration of general anesthesia. Isoflurane USP should only be delivered using a vaporizer specifically designed and designated for use with isoflurane. ( 2 ) \u2022 The administration of general anesthesia must be individualized and titrated based on the patient\u2019s age and clinical status. ( 2 )",
    "warningsAndPrecautions_original": "Isoflurane USP, is available in the following presentations:\n                  \n                     \n                        \n                           \n                              FILL\n                           \n                           \n                              CONTAINER\n                           \n                           \n                              NDC\n                           \n                        \n                        \n                           100 mL\n                           Amber-colored Bottle\n                           66794-017-10\n                        \n                        \n                           250 mL\n                           Amber-colored Bottle\n                           66794-017-25\n                        \n                     \n                  \n                  Replace the cap securely after each use.",
    "adverseReactions_original": "Isoflurane USP is contraindicated in patients:\n                  \n                  \u2022 in whom general anesthesia is contraindicated.\n                  \n                     \n\u2022 with known sensitivity to Isoflurane USP or to other halogenated agents \n  [see Warnings and Precautions (\n                     5.3\n                     )].\n                  \n                  \n                     \n\u2022 with known or suspected genetic susceptibility to malignant hyperthermia \n  [see Warnings and Precautions (\n                     5.1\n                     ), Clinical Pharmacology (\n                     12.5\n                     )].\n                     \n                     \n\u2022 with a history of confirmed hepatitis due to a halogenated inhalational anesthetic or a history of unexplained moderate to severe hepatic dysfunction (e.g., jaundice associated with fever and/or eosinophilia) after anesthesia with isoflurane or other halogenated inhalational anesthetics."
}